Tiziana Life Sciences Ltd
TLSA
$1.56
$0.010.65%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 0.00% | -54.90% | 0.00% | 48.71% | 0.00% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | 51.22% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.00% | 125.42% | 0.00% | 195.09% | 0.00% |
| Change in Net Operating Assets | 0.00% | -232.78% | 0.00% | -53.30% | 0.00% |
| Cash from Operations | 0.00% | -581.50% | 0.00% | 109.29% | 0.00% |
| Capital Expenditure | 0.00% | 64.29% | 0.00% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 0.00% |
| Cash from Investing | 0.00% | 64.29% | 0.00% | 98.60% | 0.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | -4.35% | 0.00% | 15.85% | 0.00% |
| Issuance of Common Stock | 0.00% | -- | -- | -- | 0.00% |
| Repurchase of Common Stock | 0.00% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 0.00% |
| Cash from Financing | 0.00% | 6,653.62% | 0.00% | -188.46% | 0.00% |
| Foreign Exchange rate Adjustments | 0.00% | 100.81% | 0.00% | -98.92% | 0.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.00% | 4,994.34% | 0.00% | 99.02% | 0.00% |